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ABSTRACT
Indonesians have been using herbal medicines for a long time to cure some illnesses. Carica papaya L is an example 
of an herb that contains papain enzymes, saponins, lysozymes, lipases, flavonoids, polyphenols and vitamin C. These 
ingredients are believed to be beneficial for the wound healing process. The purpose of this study was to determine the 
effect of topical application of ethanolic extract of Carica papaya L to the healing process of rat mouth ulcer. Subjects 
were 32 Wistar rats divided into 2 groups (control group and treatment group), each group containing 16 rats. All subjects 
were made to suffer from ulcers using glacial acetyl acid applied for 40 seconds in the buccal mucosa. Treatment group 
was treated with papaya leaf ethanolic extract on ulcers twice a day using microbrush, while the ulcer in the control 
group was not treated with the extract. The ulcerated tissue was biopsied and stained with H&E.  Observations were 
performed on the day 0, 3rd, 7th and 12th on HE slides. Data were observed by looking at three indicators of wound healing 
i.e. macrophage, angiogenesis and re-epithelisation. Number of macrophages and angiogenesis were analyzed using 
two-way ANOVA. Data of epithelial thickness were analyzed using Kruskal-Wallis test. The post hoc test in the treatment 
group and the control group on day 0 showed results of p = 1.00. On day 3, day 7 and day 12, the result of p was <0.05. 
In the treatment group on day 0 compared to the treatment group on the 3rd, 7th, 12th day, the results were p<0.05. In the 
treatment group on the 3rd day compared to the 7th and 12th days the results were p>0.05. The treatment group on the 7th 
day compared to the treatment group on the 12th day had p>0.05. In the control group, on day 0 compared to day 3, the 
results of p>0.05, while the control group day 0 with day 7, 12 had a result of p<0.05. The control group on the 3rd day 
was compared with the 7th day. The 12th also had a result of p<0.05. The comparison between the 7th and 12th day control 
groups showed p of >0.05. These data suggest that the papaya leaf ethanolic extract could accelerate the healing of oral 
ulcer on the buccal mucosa of wistar rats.
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INTRODUCTION
One type of medicinal plant that is often used in 
traditional medicine is papaya (Carica papaya L). 
Papaya plant is one of the plants that almost all 
its parts are useful. One part of papaya plants that 
has many benefits is the leaf. Papaya leaf contain 
papain enzymes, saponins, lysozymes, lipases, 
flavonoids and vitamin C that are believed to be 
beneficial to the wound healing process, including 
in oral ulcers.1
Papain enzyme is an endoprotein similar to the 
enzyme pepsin in humans that are anti-bacterial, 
anti-inflammatory and eliminate debris function. 
Topically proven papain proved to be useful as 
wound debridement, anti-inflammatory and anti-
edema.2 Papain enzymes have anti-inflammatory 
and analgesic effects by neutralizing inflammatory 
mediators such as quinine and prostaglandins that 
inhibit directly on pain receptors.3
Papaya leaf contain a variety of nutrients 
including vitamin A, vitamin B1, and vitamin C. In 
100 grams of fresh papaya leaf, there are 140 mg of 
vitamin C. Vitamin C can form as L-dehydroaskorbat 
acid, both of which are active substances of vitamin 
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C. Vitamin C is included in water-soluble vitamins, 
and it has an important effect in the formation of 
collagen, an important component of forming 
connective tissue in the body. Adequate collagen 
synthesis is necessary for strong ligaments, 
tendons, skin dentine, blood vessels, and bones, 
and for wound healing processes. Vitamin C can 
protect phagocytic activity from auto-oxidation, 
increase the production of interleukin-1 and 
TNF-α, and increase phagocytosis of NK cells and 
macrophage cells. In addition, vitamin C also inhibits 
tissue damage by inhibiting excessive production of 
reactive oxygen speciesi (ROS).4
Saponin stimulates the activity of TGF-β that 
is capable of affecting the perisite that governs 
the proliferation, migration and differentiation of 
cells.5 The presence of endothelial cell activation, 
platelets, macrophages, fibroblasts, and local 
cytokine release will trigger endothelial cells to 
enter and migrate to the extracellular matrix, which 
then proliferates and forms new young tubules. 
Saponins can also trigger the formation of collagen 
that plays a role in the wound healing process.6
Mucosal ulcers are the most commonly found 
mouth disease. Ulcers in the mucous membranes 
are common due to trauma. Oral cavity ulcers can 
cause a variety of complaints in patients, which can 
affect mouth activity ranging from pain complaints, 
mastication, ingestion and affect the quality of life of 
patients so that the process of rapid healing of mouth 
ulcers is needed. The process of wound healing 
normally follows a certain pattern, which is divided 
into several overlapping phases, characterized by 
cellular, vascular and biochemical changes. These 
phases include hemostasis and inflammation, 
proliferation, and maturation or remodeling. This 
phase runs from wound to healing. All types of 
wounds must pass through these phases in order 
to create the restoration of scar tissue integrity as 
expected.7
The aims of this study is to examine the effect 
of topical application of papaya leaf ethanolic extract 
(Carica papaya L) to the process of healing mouth 
ulcers in mice. The healing process was observed 
with three indicators namely macrophages, 
angiogenesis and re-epithelization.
MATERIALS AND METHODS
This study was an experimental study with 
randomized control group. The independent 
variable was papaya (Carica papaya L) leaf 
ethanolic extract. The dependent variables was 
the number of macrophages, while angiogenesis 
was expressed as the number of blood cell and re-
epithelialization thickness.
The papaya leaves were dried and mashed 
with a grinding machine. Papaya leaf powder of 
100 grams was poured in a dark colored container, 
added with 70% ethanol of 750 ml, and was stirred 
until homogeneous. It was closed immediately and 
then stored in a room, which was protected from 
sunlight for 5 days and was often shaken. The 
immersion was filtered with a flannel cloth, and the 
pulp was washed with solvent to a volume of 750 
ml. The results were concentrated with a vacuum 
evaporator until thick extracts were obtained.
Subject of this study were 32 Wistar rats divided 
into 2 groups (control and treatment group). The 16 
rats were included in each group. All subjects were 
made to suffer from ulcers using glacial acetyl acids 
applied for 40 seconds in the buccal mice of Wistar 
rats using 4 mm diameter whatman paper, which 
had been soaked for 1 minute. Treatment group 
was applied with papaya leaf ethanolic extract on 
ulcers twice a day using microbrush, at 8 am and 
4 pm, while the ulcer in the control group was not 
applied with the extract. The ulcerated tissue was 
biopsied and stained with HE. Observations were 
performed on the day 0, 3rd, 7th and 12th at three 
indicators of wound healing (macrophages, number 
of blood cell and re-epithelialization thickness).
RESULTS
This research has been declared ethically feasible 
by the ethics and advocacy unit of the Faculty 
of Dentistry, Universitas Gadjah Mada. Ethical 
Clearance Number 00848/KKEP/FKG.UGM/
EC/2016.
The study of the average study number of 
macrophages can be seen in Table 1 and Figure 
1. From Table 1, it is apparent that there are 
differences in mean number of macrophages in the 
control group and the treatment group. The highest 
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average number of macrophages is on the 3rd day in 
the control group as well as in the treatment group, 
but it decreased there after. 
The normality test of Shapiro Wilk obtained 
the p value of >0.05, which indicated that the 
distributed data are normal. Analized homogenity 
by using Levene Test obtained p value of >0.05. 
There is no difference of variance between two 
groups or variant of homogeneous data. Data were 
qualified for normality and homogeneity and thus 
can be followed by two-way ANOVA test.
In the independent group, there is a significant 
difference between the number of macrophages in 
the control group and the treatment group. In the 
day variable, p=0.00 (p<0.05). It means that there 
is a significant difference between the number of 
macrophages between observation days, such 
as day 0, 3rd, 7th, and 12th. Interaction of group 
variables with observation day obtained p value of 
0.039, which means there is an interaction of group 
variable with day of observation to macrophage 
or there are differences of macrophage number in 
various treatment groups from time to time. 
The results of the study on the average number 
of new blood cell is presented in Table 3 and Tigure 
2. The average number of blood vessels between 
the control group and the treatment group over time 
has a difference. In the treatment group (Table 3), 
there was an increase of the mean number from 
day 0, 3rd, 7th, 12th and peak on the day 12th.
Normality test data in this research using 
Shapiro Wilk obtained p value of >0.05, which 
indicated normally distributed data. Homogenity test 
using Levene Test obtained p value of >0.05, meaning 
Table 1. Mean and standard deviation number of macrophages in the treatment group and control group
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Figure 1. Macrophage histological picture (white arrowhead) on: (A) day 0 treatment group (± 9.83); (B) day 3rd treatment 
group (± 13.33); (C) day 7th treatment group (± 11.50); (D) day 12nd of the treatment group (± 9.83); (E) day 0 control group  
(± 9.67); (F) day 3rd of the control group (± 18.83); (G) day 7th of the control group (± 15.50); (H) day 12nd of the control 
group (± 12.83) 
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that there is no difference of variance between two 
groups or variant of homogeneous data. Data were 
qualified for normality and homogenity and thus can 
be followed by two-way ANOVA test.
Two ways ANOVA in Table 4 show. The group 
variables obtained p value of 0.00 (p<0.05), which 
means that there is a significant difference between 
the number of blood vessels in the control group 
and the treatment group. In the day variable, 
p value was 0.000 (p<0.05), meaning that there 
was a significant difference between the number of 
blood vessels between observation days, namely 
day 0, 3rd, 7th, 12th. Interaction of group variable with 
observation day obtained p value of 0.10 (p>0.05), 
meaning that there was no interaction of group 
variable with observation day to blood vessel or 
there was no significant difference in the number 
of blood vessels in various treatment groups from 
time to time. 
The results of the research on the average 
number of epithelium are presented in Table 5 
and Figure 3. There is an increase in the average 
number of epithelium on the 7th and 12th days both in 
the control group and the treatment group (Table 5). 
The standard deviations from each group on the 7th 
and 12th days show a high value. It is possible that 
the highest mean value has a very large difference 
to the lowest average value of each day with the 
possibility of abnormally distributed data.
The Shapiro Wilk data normality test shows 
p>0.05, which means the data have abnormal 
distribution. Because the data distribution is not 
normal, the next data analysis using non-parametric 
test is Kruskal-Wallis test. The Kruskal-Wallis 
test showed significance value of 0.00 (p<0.05) 
indicating that there was a significant difference 
between the two control groups and the treatment 
on the calculation of epithelial thickness.
Table 3. Mean and standard deviation number of blood vessel in the treatment group and control group
 Group
 Day 0 Day 3rd Day 7th Day 12th 
Mean
Standard
deviation
Mean
Standard
deviation
Mean
Standard
deviation
Mean
Standard
deviation
Treatment 1.67 0.81 4.33 1.21 5.83 1.47 7.67 1.03
Control 1.67 0.81 2.16 0.75 4.16 1.32 5.50 1.76
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Figure 2. Histological description number of blood cell (white arrowhead) on: (A) day 0 of the treatment group (± 1.67); 
(B) day 3rd of the treatment group (± 4.33); (C) day 7th of the treatment group (± 5.83); (D) day 12nd of treatment groups       
(± 7.67); (E) day 0 of the control group (± 1.67); (F) day 3rd of the control group (± 2.16); (G) day 7th of the control group 
(± 4.16); (H) day 12nd of the control group (± 5.50) 
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Group 
 Day 7th  Day 12th  
Mean Standard deviation Mean Standard deviation 
 Treatment 46.83 10.88 174.11 29.35 
Control 26.83 9.94 102.73 28.93 
 
 
                        (A)                                         (B)                                           (C)                                             (D) 
 
                       (E)                                         (F)                                               (G)                                          (H) 
Figure 3. Histology of re-epithelialization (white arrowhead) at: (A) day 0 of the treatment group; (B) day 3 of the treatment 
group; (C) The 7th day of the treatment group (± 46.83 µm); (D) day 12nd of the treatment group (± 174.11 µm); (E) day 0 
of the control group; (F) day 3rd of the control group; (G) day 7th of the control group (± 26.83 µm); (H) day 3rd of the control 
group (± 102.73 µm) 
Variable F p 
Group 18.837 0.00 
Days 38.004 0.00 
Group * Days 2.209 0.10 Femilian, et al: The effect of papaya leaves … 
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(B) day 3rd of the treatment group (± 4.3 ); (C) day 7th of the treatment group (± 5.83); (D) day 12nd of treatment groups  
(± 7.67); (E) day 0 of the control group (± 1.67); (F) day 3rd of the control group (± 2.16); (G) day 7th of the control group 
(± 4.16); (H) day 12nd of the control group (± 5. 0) 
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Figure 3. Histol gy of re- pithelialization (white ar owhead) at: (A) day 0 of the treatment group; (B) day 3 of the treatment 
group; (C) The 7th day of the treatment group (± 46.83 µm); (D) day 12nd of the treatment group (± 174.1  µm); (E) day 0
of the control group; (F) day 3rd of the control group; (G) day 7th of the control group (± 26.83 µm); (H) day 3rd of the control 
group (± 102.73 µm) 
Variable F p 
Group 18. 37 0.  
Days 38.0 4 0.  
Group * Days 2. 09 0.10 Femil an, et al: The ff ct of pa y  leaves … 
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Figure 2. Histol gical descript on u ber of blo d cel  (white ar owhead) on: (A) day 0 of the treat ent group (± 1.67); 
(B) day 3rd of the treat ent group (± 4.3 ); (C) day 7th of the treat ent group (± 5.83); (D) day 12nd of treat ent groups 
(± 7.67); (E) day 0 of the control group (± 1.67); (F) day 3rd of the control group (± 2.16); ( ) day 7th of the control group 
(± 4.16); (H) day 12nd of the control group (± 5. 0) 
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Figure 3. Histol gy of re- pithelia zation (white ar owhead) at: (A) day 0 of the treat ent group; (B) day 3 of the treat ent 
group; (C) The 7th day of the treat ent group (± 46.83 µ ); (D) day 12nd of the treat ent group (± 174.1  µ ); (E) day 0 
of the control group; (F) day 3rd of the control group; ( ) day 7th of the control group (± 26.83 µ ); (H) day 3rd of the control 
group (± 102.73 µ ) 
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roup 18. 37 0.  
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Figure 2. Histological description number of blood vessel (white arrowhead) on: (A) day 0 of the treatment group 
(± 1.67); (B) day 3rd of the treatment group (± 4.33); (C) day 7th of the treatment group (± 5.83); (D) day 12nd of 
treatment groups (± 7.67); (E) day 0 of the control group (± 1.67); (F) day 3rd of the control group (± 2.16); (G) day 7th 
of the control group (± 4.16); (H) day 12nd of the control group (± 5.50)
Table 2. Two-way analysis of variance (ANOVA) of macrophages number
Variable F p
Group 20.281 0.000
Days 16.109 0.000
Group *days 3.067 0.039
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Table 5. Mean and SD number of re-epithelisation in the control group and treatment group
Group
 Day 7th Day 12th 
Mean Standard deviation Mean Standard deviation
Treatment 46.83 10.88 174.11 29.35
Control 26.83 9.94 102.73 28.93
     
   
                      (A)                                            (B)                                             (C)                                             (D) 
     
                      (E)                                              (F)                                               (G)                                              (H) 
Figure 2. Histological description number of blood cell (white arrowhead) on: (A) day 0 of the treatment group (± 1.67); 
(B) day 3rd of the treatment group (± 4.33); (C) day 7th of the treatment group (± 5.83); (D) day 12nd of treatment groups       
(± 7.67); (E) day 0 of the control group (± 1.67); (F) day 3rd of the control group (± 2.16); (G) day 7th of the control group 
(± 4.16); (H) day 12nd of the control group (± 5.50) 
 
Table 4. Two W y ANOVA test 
 
 
 
 
 
 
Table 5. Mean and SD number of re-epithelisation in the control group and treatment group 
Group 
 Day 7th  Day 12th  
Mean Standard deviation Mean Standard deviation 
 Treatment 46.83 10.88 174.11 29.35 
Control 26.83 9.94 102.73 28.93 
 
 
                        (A)                                         (B)                                           (C)                                             (D) 
 
                       (E)                                         (F)                                               (G)                                          (H) 
Figure 3. Histology of re-epithelialization (white arrowhead) at: (A) day 0 of the treatment group; (B) day 3 of the treatment 
group; (C) The 7th day of the treatment group (± 46.83 µm); (D) day 12nd of the treatment group (± 174.11 µm); (E) day 0 
of the control group; (F) day 3rd of the control group; (G) day 7th of the control group (± 26.83 µm); (H) day 3rd of the control 
group (± 102.73 µm) 
Variable F p 
Group 18.837 0.00 
Days 38.004 0.00 
Group * Days 2.209 0.10 Femilian, et al: The effect of papaya leaves … 
Figure 3. Histology of re-epithelialization (white arrowhead) at: (A) day 0 of the treatment group; (B) day 3 
of the treatment group; (C) The 7th day of the treatment group (± 46.83 µm); (D) day 12nd of the treatment group 
(± 174.11 µm); (E) day 0 of the control group; (F) day 3rd of the control group; (G) day 7th of the control group 
(± 26.83 µm); (H) day 3rd of the control group (± 102.73 µm)
DISCUSSION
The results correspond to the theory that after 
wounding, neutrophils will migrate to the wound 
area during the first 24 hours of functioning to 
phagocytosis foreign bodies and bacteria, and it 
will be replaced by macrophage cells on day two 
or three that have a greater role in wound healing. 
Macrophages also act as antigen presenting cells 
during the wound healing process by synthesizing 
various growth factors. Macrophages that are 
affected by various mediators are found in the 
microenvironment around the wound, causing 
macrophage cells to undergo a change in properties 
according to need at the wound site. The highest 
peak of macrophage increase occurred on the day 
5th.8
Angiogenesis is stimulated by angiogenic 
growth factors such as TGF-β and VEGF. This 
growth factor binds to the receptor on the surface 
of the endothelium. The activated endothelial cells 
Table 4. Two Way ANOVA test of blood vessel
Variable F p
Group 18.837 0.00
Days 38.004 0.00
Group * Days 2.209 0.10
Table 6. Kruskal wallis test of re-epithelisation
Epitel
Chi-square 46.300
df 7
Asymp. sig. .000
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then proliferate and grow outward through the 
basal membrane to form the capillary buds that will 
become new blood vessels. Growth factors and 
chemical mediators are released by platelets and 
epidermal cells. Re-epithelization occurring in the 
proliferative and cytokine phases involved are EGF 
and TGF-α produced by platelets and keratinocytes. 
Because this process has a high metabolic activity, 
there will be an increase in the need for oxygen 
and nutrients. The need for increased oxygen and 
nutrients results in an increase in the formation of 
new blood vessels or angiogenesis. Papaya leaf is 
one of the plants that have antibacterial and anti-
inflammatory effect. These effects are resulted 
from the active ingredients, namely flavonoids 
and papain enzymes. Papain enzyme is one of 
the most potent anti-inflammatory agents. This 
papain enzyme will work with vitamins A, C and E 
to prevent inflammation.9 In addition, this papain 
enzyme is a proteolytic enzyme that has the ability 
to break protein bonds into arginine. Arginine will 
increase the activity of macrophage phagocytosis 
by producing nitric oxide (NO), which will act as 
a toxic mediator and is in charge of eliminating 
bacteria.
Flavonoids are active ingredients that have 
anti-inflammatory effects.10 Flavonoids can block 
the pathway of cyclooxygenase and lipooksigenase 
from arachidonic acid metabolism, leading to 
the synthesis of inflammatory mediators such as 
prostagladin, thromboxane inhibited to decrease 
inflammation.11 The content of saponins in papaya 
leaf will stimulate the activity of TGF-β, which 
is capable of affecting the pericite of a kind of 
smooth muscle attached outside the capillary 
vessel that regulates proliferation, migration and 
cell differentiation. The presence of activation of 
endothelial cells, platelets, fibroblasts, and cytokine 
release locally will trigger endothelial cells to enter 
and migrate to the extracellular matrix, which then 
proliferates and forms new young tubules. Saponins 
can also trigger the formation of collagen that plays 
a role in the wound healing process. In addition to 
papain and flavonoid enzymes, papaya leaf also 
contain vitamin C. The role of vitamin C (ascorbic 
acid) is very important in collagen synthesis; the 
absence of vitamin C will cause interference in 
prokolagen and decrease collagen synthesis by 
connective tissue.12
Ulcer healing process consists of three 
phases of the inflammatory phase, proliferation 
phase and remodeling phase. Macrophages begin 
to appear in the inflammatory phase, peaking at 
day 5th and decreasing thereafter. Angiogenesis 
and re-epithelialization marked the occurrence of 
a proliferative phase that began on 3 days after 
the injury. Macrophages, angiogenesis, and re-
epithelization are sequences of events that overlap 
and cannot be separated in the healing process. 
The healing process seen from the three indicators 
can be presented in graphical form as in Figure 4.
Macrophages act as antigen and phagocytic 
presenting cells during the wound healing process. 
They are also considered to have a role in the healing 
process through the synthesis of various growth 
factors. Macrophages that are affected by various 
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Figure 4. Graph of the healing process on three parameters
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mediators are found in the microenvironment around 
the wound, causing macrophage cells to undergo 
character changes according to the need at the 
wound site. When the need for macrophages at the 
wound site decreases, the number of macrophages 
will also decrease.
Angiogenesis is stimulated by angiogenic 
growth factors such as TGF-β and VEGF. This 
growth factor binds to the receptor on the surface 
of the endothelium. The activated endothelial cells 
then proliferate and grow outward through the 
basal membrane to form the capillary buds that will 
become new blood vessels. Growth factors and 
chemical mediators are released by platelets and 
epidermal cells.
Re-epithelization occurring in the proliferative 
and cytokine phases involved are EGF and TGF-α 
produced by platelets and keratinocytes. Because 
this process has a high metabolic activity, there will 
be an increase in the need for oxygen and nutrients. 
The need for increased oxygen and nutrients results 
in an increase in the formation of new blood vessels 
or angiogenesis that is primarily affected by VEGF, 
bFGF and TGF-β.
Some obstacles found during the experiment 
was the researcher`s inability to control the rat`s 
habit to lick the ulcer area after application of 
extracts. Rat habits to lick the area of the ulcer can 
cause the extract no longer be attached to the ulcer, 
which needs to be anticipated. Another obstacle 
was the calculation of angiogenesis, only by blood 
vessels containing erythrocytes can be read and 
not all blood vessels contain erythrocytes. Staining 
preparations only use HE routine staining making 
it difficult to clearly observe endothelial cells. It is 
considerable to use immunohistochemical staining 
to provide clearer information about the content of 
various molecular elements in the cell.
CONCLUSION
The topical application of papaya leaf ethanolic 
extract can significantly accelerate the healing 
process of oral ulcers in Wistar rats. This conclusion 
is seen from three indicators of healing: macrophage 
cells, angiogenesis, and re-epithelization.
Subsequent studies should consider the 
addition of observation days to enable the 
observation of the entire healing process. It is 
also suggested that the papaya leaf ethanolic 
extract is made in gel in orabase preparations for 
easier attachment and insolubility in saliva. Further 
research is needed related to toxic effects of papaya 
leaf.
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